Life inside the seesaw struggle of dual addiction.
As opioid addiction and overdoses escalated into an epidemic, many surgeons continued to hand out far more pills than needed for postoperative pain relief
All eyes will be on Oklahoma this week when the first case in a flood of litigation against opioid drug manufacturers begins Tuesday.
Federal agencies are urging doctors to evaluate the risks to patients on opioid pain medicines before abruptly tapering them off the highly addictive drugs.
The trend has a big impact on states, whose budgets often already are overstretched responding to the drug crisis and other needs.
First came prescription pain medications, then heroin, and now fentanyl.
The trial will for the first time provide access to evidence aimed at showing that drug companies flooded markets with opioids, knowing that they were addictive.
Detoxing off heroin or opioids without medication is sheer hell. I should know.
Reformulation of the OxyContin to make it more difficult to abuse directly led to a large rise in hepatitis C infections as drug abusers to injectable heroin
The annual number of opioid overdose deaths will increase to 81,700 in 2025, the study projects.
The first 9 months of 2013, Purdue Pharma, the maker of the addictive opioid pain drug OxyContin, paid the Sackler family $400 million from its profits
Purdue Pharma considered capitalizing on the addiction treatment boom — while going to extreme lengths to boost sales of its controversial opioid.
Seven overdoses were reported January 17th. Some victims reported injecting heroin and others snorting a crushed pill that may have been fentanyl.